|
|
|
|
|
|
- Mountain View Pharmaceuticals
The company is dedicated to the development and application of innovative chemical technology for enhancing the utility of protein- and virus-based pharmaceuticals.
- Microcide Pharmaceuticals
Microcide Pharmaceuticals, Inc. is a biopharmaceutical company whose mission is to discover, develop and commercialize novel antimicrobials for the treatment of serious bacterial, fungal and viral infections.
- Maxim Pharmaceuticals
Maxim is developing treatments for cancer and infectious diseases designed to extend survival while maintaining a good quality of life. Maxim' s lead drug Maxamine has shown substantial promise in Phase II trials.
- Matrix Pharmaceutical
Matrix Pharmaceutical is a development stage company engaged in the formulation and development of novel pharmaceutical product candidates that are designed to improve the delivery of cancer drugs to more effectively treat solid tumors.
- Ligand Pharmaceuticals
Ligand Pharmaceuticals is committed to the discover, development, marketing and distribution of novel, small molecule pharmaceutical products.
- La Jolla Pharmaceutical Company
Research-based biopharmaceutical company targeting at B-cell related autoimmune diseases such as Lupus and thrombosis; DNA contract manufacturing.
- Kosan Biosciences
KOSAN Biosciences is an early-stage biotechnology company working in the area of Combinatorial Biosynthesis. Develops new pharmaceuticals through the generation of novel analogs of natural products by genetic engineering of biosynthetic pathways.
- Isis Pharmaceuticals
Engaged in the discovery and development of a new class of drugs, antisense oligonucleotides, which may form a new basis for therapeutic drugs that are safer and more effective.
- IntraBiotics Pharmaceuticals
Biopharmaceutical company developing novel antibacterial and antifungal drugs for the prevention or treatment of serious infectious diseases.
- InterMune Pharmaceuticals
InterMune Pharmaceuticals develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders.
- Insite Vision
Insite Vision, Inc. is engaged in the development of ophthalmic drugs and ophthalmic drug delivery systems, utilizing a glaucoma genetics program, the DuraSite delivery system, and a retinal delivery system.
- Impax Laboratories
Engaged in development, manufacturing and marketing of specialty prescription pharmaceutical products utilizing our formulation expertise and unique drug delivery technologies.
- IDEC Pharmaceuticals
IDPH is primarily engaged in the commercialization & research and development of targeted therapies for the treatment of cancer and autoimmune and inflammatory diseases.
- ICN Pharmaceuticals
Growth Hormone Deficiency Study Currently Recruiting Patients. Growth Hormone Deficiency Study Currently Recruiting Patients. Product Line Includes VIRAZOLEr (ribavirin for inhalation solution).
- Hollis-Eden Pharmaceuticals
Hollis-Eden Pharmaceuticals is dedicated to the development and commercialization of therapeutic and preventive pharmaceutical agents for infectious diseases and immune system disorders including HIV/AIDS, hepatitis and malaria.
|
|
|
»ç¿ë»ó °ÇÀÇ»çÇ× ¹× À߸øµÈ ºÎºÐÀ̳ª
Ʋ¸° ³»¿ëÀÌ ÀÖÀ¸¸é,
¹Ù·Î ¿¬¶ôÁÖ¼¼¿ä. °¨»çÇÕ´Ï´Ù. |
|
¡¡¡¡¡¡¡¡¡¡¡¡¡¡
Help : service@kr.chemnet.com |
|
|